Boulder Peptide Symposium 2013
Start: Wednesday, September 25, 2013 @ 12:00 PM (MDT)
Boulder , CO 80302
PEPTIDES IN ONCOLOGY
The theme for this year's Boulder Peptide Symposium is Peptides in Oncology. While the use of peptides as cancer killing agents is one obvious use, peptides are also used as diagnostic markers and by extension homing beacons to carry cytotoxic agents to cancer cells. With recent advances in technology peptides can now also penetrate the cell membrane to access intracellular binding sites. As such peptides can function either as a cell penetrating agents or be used to modulate internal signalling pathways by binding to selective targets. Finally peptides are also being evaluated as components of subunit vaccines to treat cancer. Presentations and panel discussions at the symposium shall highlight advances in these areas.
ABOUT THE BOULDER PEPTIDE SYMPOSIUM
The Boulder Peptide Symposium seeks to bring together key decision leaders from both industry and academia to discuss the future of peptide therapeutics. Peptide therapeutics are potent and highly selective yet their development into effective treatments can be challenged by limited delivery routes, product stability, manufacturing challenges and an evolving regulatory landscape. BPS is the key forum where these challenges will be identified, discussed, and one day—addressed.
|Sept 25||Peptide Showcase |
Short presentations from companies developing new peptides or related technologies.
|Sept 26||Session I - Peptides in the Clinic |
Updates on development programs for therapeutic peptides
Session II - Peptide Drug Delivery and Formulation
Presentations on improving half-life, oral and parenteral delivery systems and interesting peptide formulation challenges
|Sept 27||Session III - Advances in Peptide Chemistry and Analytics |
Highlights of recent advances in peptide synthetic methods and analytical techniques